Evidence map›Paper›PMID 27425827›Full record

ArticleMolecular microbiology2016

Invasion of hepatocytes by Plasmodium sporozoites requires cGMP-dependent protein kinase and calcium dependent protein kinase 4.

K Govindasamy, S Jebiwott, D K Jaijyan, A Davidow, K K Ojo, W C Van Voorhis, M Brochet, O Billker, P Bhanot

Open access · greenAbstract read
In one paragraph

Article in Molecular microbiology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 53 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
53citing papers in PubMed, 1 pooled it
7.0field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

53 citing papers in PubMed, 1 synthesis or guideline pooled it, 75 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Discovery of Imidazole-Based Inhibitors ofACS medicinal chemistry letters · 2021
    Article
  17. Review
  18. Article
  19. Malaria parasite egress at a glance.Journal of cell science · 2021
    Review
  20. CaScience advances · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 4 countries.

K GovindasamyDepartment of Microbiology, Biochemistry and Molecular Genetics, Rutgers - New Jersey Medical School, Newark, NJ, USA.
S JebiwottDepartment of Microbiology, Biochemistry and Molecular Genetics, Rutgers - New Jersey Medical School, Newark, NJ, USA.
D K JaijyanDepartment of Microbiology, Biochemistry and Molecular Genetics, Rutgers - New Jersey Medical School, Newark, NJ, USA.
A DavidowDepartment of Biostatistics, Rutgers - School of Public Health, Newark, NJ, USA.
K K OjoDivision of Allergy and Infectious Diseases, Center for Emerging and Re-emerging Infectious Diseases, University of Washington, Seattle, WA, USA.
W C Van VoorhisDivision of Allergy and Infectious Diseases, Center for Emerging and Re-emerging Infectious Diseases, University of Washington, Seattle, WA, USA.
M BrochetCNRS UMR5235 -Université Montpellier 2, 34095, Montpellier, France.
O BillkerWellcome Trust Sanger Institute, Malaria Programme, CB10 1SA, Hinxton, UK.
P BhanotDepartment of Microbiology, Biochemistry and Molecular Genetics, Rutgers - New Jersey Medical School, Newark, NJ, USA. bhanotpu@njms.rutgers.edu.
Rutgers, The State University of New Jersey · USNational Center for Emerging and Zoonotic Infectious Diseases · USRutgers New Jersey Medical SchoolUniversité de Montpellier · FRWellcome Sanger Institute · GB

Funding

Development of inhibitors of P. falciparum cGMP dependent protein kinase (PfPKG) for malaria chemopreventionR01AI133633 · NIAID · RBHS-NEW JERSEY MEDICAL SCHOOL · PI BHANOT, PURNIMA, ROTELLA, DAVID · 2017 to 2019
$2.1M
Inhibitors of Plasmodium liver infectionR21AI128052 · NIAID · RBHS-NEW JERSEY MEDICAL SCHOOL · PI BHANOT, PURNIMA · 2017 to 2018
$437k
Identification of the target of a compound that inhibits plasmodium sporozoitesR21AI094167 · NIAID · UNIV OF MED/DENT OF NJ-NJ MEDICAL SCHOOL · PI BHANOT, PURNIMA · 2012 to 2013
$436k
NIAID NIH HHS R01 AI133633NIAID NIH HHS R21 AI094167NIAID NIH HHS R21 AI128052Wellcome TrustWellcome Trust WT098051
6 · The paper itself

Abstract

Invasion of hepatocytes by sporozoites is essential for Plasmodium to initiate infection of the mammalian host. The parasite's subsequent intracellular differentiation in the liver is the first developmental step of its mammalian cycle. Despite their biological significance, surprisingly little is known of the signalling pathways required for sporozoite invasion. We report that sporozoite invasion of hepatocytes requires signalling through two second-messengers - cGMP mediated by the parasite's cGMP-dependent protein kinase (PKG), and Ca

Indexed as

AnimalsAnophelesCalciumCalcium-Binding ProteinsCalcium-Calmodulin-Dependent Protein KinasesCyclic GMPCyclic GMP-Dependent Protein KinasesHepatocytesHep G2 CellsHumansPlasmodium bergheiPlasmodium falciparumProtein KinasesProtozoan ProteinsSignal TransductionSporozoitesCalciumCalcium-Binding ProteinsCalcium-Calmodulin-Dependent Protein KinasesCyclic GMPCyclic GMP-Dependent Protein KinasesProtein KinasesProtozoan Proteins

Identifiers

PMID27425827
PMCPMC8666132
OpenAlexW2495009504

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.